Usman Malik Promoted to Deputy Director, Metabolic Portfolio at CCL Pharmaceuticals

Usman Malik has been promoted to Deputy Director, Metabolic Portfolio at CCL Pharmaceuticals, marking an important milestone in his professional journey within the pharmaceutical industry. This promotion reflects his consistent performance, professional development, and the organization’s recognition of his contributions to portfolio management and commercial initiatives.

With experience in pharmaceutical operations, portfolio management, and strategic business initiatives, Usman Malik brings a focused and results-oriented approach to supporting portfolio growth and strengthening business performance. His expertise contributes to effective execution, market development, and the advancement of healthcare-focused initiatives.
In his elevated role, he will oversee key activities related to the Metabolic Portfolio, support strategic business initiatives, and contribute to CCL Pharmaceuticals’ continued focus on innovation, sustainable growth, and delivering impactful healthcare solutions.